Navidea Biopharmaceuticals

$1.74
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.16 (-8.42%) Today

$0.00 (0.00%) As of 10:00 PM UTC after-hours

Why Robinhood?

You can buy or sell NAVB and other stocks, options, and ETFs commission-free!

About NAVB

Navidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutic. It operates through the following segments: Diagnostics, Therapeutics, and Corporate.

CEO

Jed Andrew Latkin

Employees

Headquarters

Dublin, Ohio

Founded

1983

Market Cap

49.45M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

377.29K

High Today

$1.88

Low Today

$1.64

Open Price

$1.88

Volume

387.94K

52 Week High

$5.36

52 Week Low

$0.63

NAVB Earnings

-$0.17

-$0.11

-$0.06

$0.00

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

— per share

Actual

Expected May 13, After Hours